Depreciation of Cadrenal Therapeutics, Inc. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Cadrenal Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Cadrenal Therapeutics, Inc. Depreciation for the quarter ending 30 Sep 2025 was $401, a 1.5% decline year-over-year.
  • Cadrenal Therapeutics, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $6,725, a 225% increase year-over-year.
  • Cadrenal Therapeutics, Inc. annual Depreciation for 2024 was $1,880, a 5.1% decline from 2023.
  • Cadrenal Therapeutics, Inc. annual Depreciation for 2023 was $1,980, a 56% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Cadrenal Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $6,725 $401 -$6 -1.5% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $6,731 $401 -$69 -15% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $6,800 $5,517 +$4,920 +824% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $1,880 $406 -$190 -32% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q3 2024 $2,070 $407 -$190 -32% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $2,260 $470 -$127 -21% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $2,387 $597 +$407 +214% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $1,980 $596 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $597 +$91 +18% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $597 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $190 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q3 2022 $506 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3

Cadrenal Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,880 -$100 -5.1% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $1,980 +$714 +56% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $1,266 25 Jan 2022 31 Dec 2022 10-K 11 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.